OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2014
(2)
2024
(1)
2023
(1)
2022
(1)
2019
(1)
2018
(1)
2012
(1)
2009
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients.
Not available
S-EPMC6726511
|
biostudies-literature
Cite
Selection of a novel cell-internalizing RNA aptamer specific for CD22 antigen in B cell acute lymphoblastic leukemia.
Not available
S-EPMC10469072
|
biostudies-literature
Cite
Phalangeal Fractures Requiring Vascular Reconstruction: Epidemiology and Factors Predictive of Reoperation.
Not available
S-EPMC10953521
|
biostudies-literature
Cite
Metabolic flux correlations, genetic interactions, and disease.
Not available
S-EPMC2909654
|
biostudies-literature
Cite
Systems biology-based identification of Mycobacterium tuberculosis persistence genes in mouse lungs.
Not available
S-EPMC3944818
|
biostudies-literature
Cite
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.
Not available
S-EPMC4280857
|
biostudies-literature
Cite
A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom.
Not available
S-EPMC6189132
|
biostudies-literature
Cite
Epidemiology and Fracture Patterns of Traumatic Phalangeal Fractures.
Not available
S-EPMC9351885
|
biostudies-literature
Cite
Quantitative separation of monomeric U(IV) from UO2 in products of U(VI) reduction.
Not available
S-EPMC3371135
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets